ITMI20041822A1 - "agente terapeutico utile per il trattamento di neoplasie plasmacellulari" - Google Patents

"agente terapeutico utile per il trattamento di neoplasie plasmacellulari"

Info

Publication number
ITMI20041822A1
ITMI20041822A1 IT001822A ITMI20041822A ITMI20041822A1 IT MI20041822 A1 ITMI20041822 A1 IT MI20041822A1 IT 001822 A IT001822 A IT 001822A IT MI20041822 A ITMI20041822 A IT MI20041822A IT MI20041822 A1 ITMI20041822 A1 IT MI20041822A1
Authority
IT
Italy
Prior art keywords
treatment
plasmacellular
neoplasies
therapeutic agent
useful therapeutic
Prior art date
Application number
IT001822A
Other languages
English (en)
Inventor
Rosa Gobbi
Original Assignee
Pharmaproducts Uk Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pharmaproducts Uk Ltd filed Critical Pharmaproducts Uk Ltd
Priority to IT001822A priority Critical patent/ITMI20041822A1/it
Publication of ITMI20041822A1 publication Critical patent/ITMI20041822A1/it
Priority to AT05792088T priority patent/ATE413870T1/de
Priority to PCT/EP2005/010135 priority patent/WO2006032458A1/en
Priority to ES05792088T priority patent/ES2318541T3/es
Priority to CA2581379A priority patent/CA2581379C/en
Priority to EP05792088A priority patent/EP1799202B1/en
Priority to US11/663,553 priority patent/US7705051B2/en
Priority to DE602005011029T priority patent/DE602005011029D1/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/185Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19Carboxylic acids, e.g. valproic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
IT001822A 2004-09-24 2004-09-24 "agente terapeutico utile per il trattamento di neoplasie plasmacellulari" ITMI20041822A1 (it)

Priority Applications (8)

Application Number Priority Date Filing Date Title
IT001822A ITMI20041822A1 (it) 2004-09-24 2004-09-24 "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"
AT05792088T ATE413870T1 (de) 2004-09-24 2005-09-20 Therapeutisches mittel zur behandlung von plasmazellneoplasien
PCT/EP2005/010135 WO2006032458A1 (en) 2004-09-24 2005-09-20 Therapeutical agent useful for the treatment of plasma cell neoplasias
ES05792088T ES2318541T3 (es) 2004-09-24 2005-09-20 Agente terapeutico util para el tratamiento de neoplasias de celulas plasmaticas.
CA2581379A CA2581379C (en) 2004-09-24 2005-09-20 Calcium trifluoroacetate for the treatment of plasma cell neoplasias
EP05792088A EP1799202B1 (en) 2004-09-24 2005-09-20 Therapeutical agent useful for the treatment of plasma cell neoplasias
US11/663,553 US7705051B2 (en) 2004-09-24 2005-09-20 Therapeutical agent useful for the treatment of plasma cell neoplasias
DE602005011029T DE602005011029D1 (de) 2004-09-24 2005-09-20 Therapeutisches mittel zur behandlung von plasmazellneoplasien

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT001822A ITMI20041822A1 (it) 2004-09-24 2004-09-24 "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"

Publications (1)

Publication Number Publication Date
ITMI20041822A1 true ITMI20041822A1 (it) 2004-12-24

Family

ID=35266962

Family Applications (1)

Application Number Title Priority Date Filing Date
IT001822A ITMI20041822A1 (it) 2004-09-24 2004-09-24 "agente terapeutico utile per il trattamento di neoplasie plasmacellulari"

Country Status (8)

Country Link
US (1) US7705051B2 (it)
EP (1) EP1799202B1 (it)
AT (1) ATE413870T1 (it)
CA (1) CA2581379C (it)
DE (1) DE602005011029D1 (it)
ES (1) ES2318541T3 (it)
IT (1) ITMI20041822A1 (it)
WO (1) WO2006032458A1 (it)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2845591A1 (en) 2013-09-04 2015-03-11 Polichem S.A. Use of trifluoroacetic acid as keratolytic agent to treat hyperkeratotic skin lesions
KR101683635B1 (ko) 2014-12-29 2016-12-09 가천대학교 산학협력단 락테이트 금속염을 포함하는 암 치료용 약학 조성물

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1140049A (en) * 1977-12-22 1983-01-25 Dke J.E. Helgstran Pharmaceutical preparations from derivatives of hydroxycarbonylphosphonic acid
ITMI20011495A1 (it) * 2001-07-12 2003-01-12 Pharmaproducts Uk Ltd Sali di calcio ad attivita' citotossica
ITMI20040665A1 (it) * 2004-04-02 2004-07-02 Pharmaproducts Uk Ltd Sale di calcio per il trattamento della psoriasi e di dermatiti

Also Published As

Publication number Publication date
ES2318541T3 (es) 2009-05-01
US7705051B2 (en) 2010-04-27
CA2581379A1 (en) 2006-03-30
EP1799202B1 (en) 2008-11-12
CA2581379C (en) 2013-05-07
EP1799202A1 (en) 2007-06-27
DE602005011029D1 (de) 2008-12-24
ATE413870T1 (de) 2008-11-15
WO2006032458A1 (en) 2006-03-30
US20090203939A1 (en) 2009-08-13

Similar Documents

Publication Publication Date Title
MX2009006742A (es) Inhibidores acilaminopirazoles como fgfr.
TW200738725A (en) Unsaturated mTOR inhibitors
MXPA04009163A (es) Nuevos compuestos.
MXPA03007140A (es) Derivados de carbolina.
SE0301700D0 (sv) Novel compounds
EA200501849A1 (ru) Производные пиразолохиназолина: способ получения и применение в качестве ингибиторов киназ
TW200505881A (en) Tri(cyclo) substituted amide compounds
TW200801006A (en) Fused bicyclic mTOR inhibitors
TW200510375A (en) New compounds
BRPI0417717A (pt) composto, composição farmacêutica, e, uso de um composto
SE0200920D0 (sv) Novel compounds
TW200510325A (en) 2-acylamino-4-phenylthiazole derivatives, preparation thereof and therapeutic application thereof
DK1519724T3 (da) Fredericamycin-derivater som lægemidler til behandling af tumorer
CY1111470T1 (el) Νεες φαρμακευτικες συνθεσεις που περιεχουν φλιβανσερινη πολυμορφη α
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
MXPA05007609A (es) Antagonista de un receptor sensible al calcio.
MXPA03007142A (es) Derivados de carbolina.
PA8599701A1 (es) Formas de dosificacion y procedimientos de tratamiento que usan inhibidores del vegfr
EA200601837A1 (ru) Бензоксазины для лечения заболеваний дыхательных путей
SE0302546D0 (sv) New compounds
UA96969C2 (en) Acylaminopyrazoles as fgfr inhibitors
TW200639156A (en) New compounds
SE0402635D0 (sv) Chemical compounds
TW200606164A (en) New compounds
SE0200198D0 (sv) New use